AZZ (AZZ) vs Enovis (ENOV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
AZZ (AZZ) has outperformed Enovis (ENOV) over the past year, gaining 14.3% versus a loss of 11.5%. Over five years, AZZ leads with a +121.2% price change compared with -69.5% for ENOV. AZZ is the larger company by market cap ($3.51 billion vs $1.47 billion), about 2.4 times the size, while Enovis is growing revenue faster (+6.7% vs +4.6%).
On valuation, Enovis trades at a lower forward P/E (7.4x vs 14.8x for AZZ). AZZ pays a dividend yielding 0.72%, while Enovis does not currently pay one. AZZ converts more of its revenue into profit, with a net margin of 19.2% versus -52.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZZ | ENOV |
|---|---|---|
| Share price | $117.37 | $25.47 |
| Market cap | $3.51B | $1.47B |
| 1-day change | -4.58% | -2.90% |
| YTD return | +9.51% | -4.39% |
| 1-year return | +14.26% | -11.47% |
| 5-year return | +121.24% | -69.49% |
| P/E ratio (TTM) | 21.15 | — |
| Forward P/E | 14.83 | 7.35 |
| EPS (TTM) | $5.55 | $-9.23 |
| Dividend yield | 0.72% | 0.00% |
| Annual dividend | $0.84 | $0.00 |
| Revenue (latest FY) | $1.65B | $2.25B |
| Revenue growth (YoY) | +4.58% | +6.66% |
| Net income (latest FY) | $317.26M | $-1.18B |
| Gross margin | 23.94% | 59.84% |
| Operating margin | 16.04% | -50.01% |
| Net margin | 19.23% | -52.69% |
| 52-week high | $162.20 | $31.67 |
| 52-week low | $101.82 | $16.70 |
| Distance from 52-week high | -27.64% | -19.58% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +38.28% | +48.53% |
| Average volume | 242.20K | 1.71M |
| Shares outstanding | 29.92M | 57.69M |
| Employees | 3,767 | 7,802 |
| Sector | Industrials | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AZZ is about 2.4 times larger than Enovis by market value ($3.51B vs $1.47B).
- AZZ has outperformed ENOV by 25.7 percentage points over the past year.
- AZZ is more profitable, keeping 19.2 cents of every revenue dollar as net income versus -52.7 cents for Enovis.
- The two companies sit in different sectors: AZZ in Industrials and Enovis in Health Care.
About AZZ
AZZ stock →AZZ Inc. provides hot-dip galvanizing and coil coating solutions in North America.
Industrials · Industrial Specialties · 3,767 employees
About Enovis
ENOV stock →Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.
Health Care · Industrial Specialties · 7,802 employees
AZZ vs ENOV FAQ
Which is bigger, AZZ or Enovis?
AZZ (AZZ) is larger, with a market capitalization of $3.51B compared with $1.47B for Enovis (ENOV).
Which stock has performed better over the past year, AZZ or ENOV?
AZZ returned +14.26% over the past 12 months, compared with -11.47% for ENOV (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, AZZ or Enovis?
AZZ pays a dividend yielding 0.72%, while Enovis does not currently pay a regular dividend.
Are AZZ and Enovis in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Industrials sector.